| Literature DB >> 8466953 |
K Hayashi1, J Kurokawa, S Nomura, Y Kuga, Y Ohkura, G Kajiyama.
Abstract
The effect of fluvastatin sodium (XU62-320), a new type of inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A, on the induction of LDL receptor in the human liver-derived cell line HepG2 was investigated. Fluvastatin sodium produced marked inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and induction of LDL receptor on HepG2 cells at a concentration of 0.1-1.0 microM. These results suggest that fluvastatin sodium has potential for use as a strong plasma cholesterol-lowering drug.Entities:
Mesh:
Substances:
Year: 1993 PMID: 8466953 DOI: 10.1016/0005-2760(93)90166-7
Source DB: PubMed Journal: Biochim Biophys Acta ISSN: 0006-3002